Andrew J. Terjesen Counsel

Save current page as PDF

Andrew focuses his practice on public and private securities offerings, liability management transactions and corporate governance matters. He has experience representing issuers and underwriters in a range of securities offerings and transactions, including Rule 144A and registered offerings of debt securities, initial public offerings, follow-on offerings of common and preferred stock, exchange offers, tender offers, consent solicitations and redemptions.

He also advises public companies regarding 1934 Act reporting and annual meeting proxy statement matters. Additionally, Andrew has represented public and private companies in mergers and acquisitions and other corporate transactions.

Prior to joining McGuireWoods, Andrew worked for over six years in the New York City office of a top-ranked global law firm on a wide range of capital markets transactions. During that time he was also seconded into the legal department of the capital markets group of a multinational financial institution.

Before law school, Andrew earned his doctorate in Philosophy and taught Philosophy at Austin College in Sherman, Texas; Washington and Lee University in Lexington, Virginia; and Rhodes College in Memphis, Tennessee.


  • Representation of Alliance Global Partners, as exclusive placement agent, in connection with a $3 million follow-on equity offering by Versus Systems Inc. (Nasdaq: VS), an engagement and rewards company that makes live events, games, shows, and apps more fun to watch and play.
  • Representation of a major financial institution in connection with public offerings of senior notes.
  • Representation of a major financial institution in connection with public offerings of preferred stock.
  • Representation of a major consumer products company in connection with a Rule 144A offering of $800 million of senior notes.
  • Representation of an international biopharmaceutical company in a public offering of American Depositary Shares.
  • Representation of a multi-office medical practice in a corporate reorganization and a $25 million minority preferred equity investment.